TY - JOUR
T1 - Brody Disease, an Early-Onset Myopathy With Delayed Relaxation and Abnormal Gait
T2 - A Case Series of 9 Children
AU - Verhoeven, Jamie I.
AU - Kramer, Jasper
AU - Seeger, Juergen
AU - Molenaar, Joery P.
AU - Braakman, Hilde
AU - Kamsteeg, Erik Jan
AU - Rodenburg, Richard J.
AU - Kusters, Benno
AU - Koudijs, Suzanne
AU - Van Engelen, Baziel G.
AU - Erasmus, Corrie E.
AU - Voermans, Nicol C.
N1 - Publisher Copyright:
© 2024 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
PY - 2024/2/19
Y1 - 2024/2/19
N2 - Brody disease is a rare autosomal recessive myopathy, caused by pathogenic variants in the ATP2A1 gene. It is characterized by an exercise-induced delay in muscle relaxation, often reported as muscle stiffness. Children may manifest with an abnormal gait and difficulty running. Delayed relaxation is commonly undetected, resulting in a long diagnostic delay. Almost all published cases so far were adults with childhood onset and adult diagnosis. With diagnostic next-generation sequencing, an increasing number of patients are diagnosed in childhood. We describe the clinical and genetic features of 9 children from 6 families with Brody disease. All presented with exercise-induced delayed relaxation, reported as difficulty running and performing sports. Muscle strength and mass was normal, and several children even had an athletic appearance. However, the walking and running patterns were abnormal. The diagnostic delay ranged between 2 and 7 years. Uniformly, a wide range of other disorders were considered before genetic testing was performed, revealing pathogenic genetic variants in ATP2A1. To conclude, this case series is expected to improve clinical recognition and timely diagnosis of Brody disease in children. We propose that ATP2A1 should be added to gene panels for congenital myopathies, developmental and movement disorders, and muscle channelopathies.
AB - Brody disease is a rare autosomal recessive myopathy, caused by pathogenic variants in the ATP2A1 gene. It is characterized by an exercise-induced delay in muscle relaxation, often reported as muscle stiffness. Children may manifest with an abnormal gait and difficulty running. Delayed relaxation is commonly undetected, resulting in a long diagnostic delay. Almost all published cases so far were adults with childhood onset and adult diagnosis. With diagnostic next-generation sequencing, an increasing number of patients are diagnosed in childhood. We describe the clinical and genetic features of 9 children from 6 families with Brody disease. All presented with exercise-induced delayed relaxation, reported as difficulty running and performing sports. Muscle strength and mass was normal, and several children even had an athletic appearance. However, the walking and running patterns were abnormal. The diagnostic delay ranged between 2 and 7 years. Uniformly, a wide range of other disorders were considered before genetic testing was performed, revealing pathogenic genetic variants in ATP2A1. To conclude, this case series is expected to improve clinical recognition and timely diagnosis of Brody disease in children. We propose that ATP2A1 should be added to gene panels for congenital myopathies, developmental and movement disorders, and muscle channelopathies.
UR - https://www.scopus.com/pages/publications/85185704843
U2 - 10.1212/WNL.0000000000209164
DO - 10.1212/WNL.0000000000209164
M3 - Article
C2 - 38373275
AN - SCOPUS:85185704843
SN - 0028-3878
VL - 102
JO - Neurology
JF - Neurology
IS - 5
M1 - e209164
ER -